Medication Guide - 1/22/2021

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Spritam Levetiracetam TABLET, FOR SUSPENSION;ORAL 207958 APRECIA PHARMS 01/19/2021 Cellcept Mycophenolate Mofetil CAPSULE;ORAL 050722 ROCHE PALO 01/15/2021 Cellcept Mycophenolate Mofetil TABLET;ORAL 050723 ROCHE PALO 01/15/2021 Cellcept Mycophenolate Mofetil Hydrochloride INJECTABLE;INJECTION 050758 ROCHE PALO 01/15/2021 Cellcept Mycophenolate Mofetil SUSPENSION;ORAL 050759 ROCHE PALO 01/15/2021 Enhertu Fam-Trastuzumab Deruxtecan-Nxki INJECTABLE;INJECTION 761139 DAIICHI SANKYO 01/15/2021 Myfortic Mycophenolic Acid TABLET, DELAYED RELEASE;ORAL 050791 NOVARTIS 01/15/2021 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA